Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.

Muscle & nerve

Volumn 48, Issue 6, 2013, Pages 992-993

  Yi, John S ^a   Decroos, Emily C ^b   Sanders, Donald B ^b   Weinhold, Kent J ^b   Guptill, Jeffrey T ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; MONOUNSATURATED FATTY ACID; MUSK; RITUXIMAB;

B LYMPHOCYTE; CASE REPORT; CELL COUNT; FEMALE; HUMAN; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYASTHENIA GRAVIS; PATHOLOGY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD19; B-LYMPHOCYTES; CELL COUNT; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC FACTORS; MIDDLE AGED; MYASTHENIA GRAVIS;

EID: 84891916915     PISSN: None     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24063     Document Type: Letter

References (0)